Cargando…
The clinical efficacy of orexin antagonists for primary insomnia- A review of the evidence
INTRODUCTION: Primary insomnia is frequently present in the general population, with epidemiologic research reporting prevalence values from 10% to as high as 60%. Chronic insomnia is associated with a significant impact on professional, academic, and daily life functionality, and it also may be res...
Autor principal: | Vasiliu, O. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cambridge University Press
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10479459/ http://dx.doi.org/10.1192/j.eurpsy.2023.2346 |
Ejemplares similares
-
Orexin receptor antagonists as therapeutic agents for insomnia
por: Equihua, Ana C., et al.
Publicado: (2013) -
Evidence‐based insomnia treatment strategy using novel orexin antagonists: A review
por: Kishi, Taro, et al.
Publicado: (2021) -
Suvorexant: The first orexin receptor antagonist to treat insomnia
por: Dubey, Ashok K., et al.
Publicado: (2015) -
Different doses of dual orexin receptor antagonists in primary insomnia: a Bayesian network analysis
por: Xue, Tao, et al.
Publicado: (2023) -
Pharmacological Management of insomnia Associated with Parkinson’s Disease
por: Vasiliu, O.
Publicado: (2022)